Pharmafile Logo
Pharmafocus logo
Advanced Search

Research and Development

Showing 15 posts of 9607 posts found.

az

Sierra Oncology to licence myelofibrosis candidate from AstraZeneca

August 6, 2021 Medical Communications, Research and Development, Sales and Marketing

Under a new agreement announced on Friday, AstraZeneca will licence AZD5153, a potent and selective BRD4 BET inhibitor with a …
News

Cholesterol pill could cut COVID infections by up to 70%, study finds

August 6, 2021 Medical Communications, Research and Development

A licensed drug normally used to treat abnormal levels of fatty substances in the blood could reduce COVID infections by …
News

Tokyo COVID: Cases surge as Delta variant takes hold, hospital policy U-turn expected

August 4, 2021 Medical Communications, Research and Development

Japan has warned that COVID-19 cases are surging at an ‘unprecedented pace’, hitting record highs in Tokyo amid the Olympic …
News

Delta surge: China reports highest rate of new COVID cases since Jan

August 4, 2021 Medical Communications, Research and Development

On Wednesday China reported the highest number of new locally transmitted COVID-19 cases since January, with case numbers being driven …
News

Chilean study reveals success of various COVID-19 vaccines

August 4, 2021 Research and Development

Chilean authorities have released real world data on the varied success of the Sinovac, Pfizer, and AstraZeneca COVID-19 vaccines.Among the …
News
lilly_entrance_web_42

Eli Lilly to seek approval for experimental Alzheimer’s drug by end of year

August 4, 2021 Research and Development

Eli Lilly and Co plans to seek US approval for its experimental Alzheimer’s drug by the end of the year, …
News

Over 1 million 16 and 17-year-olds set to be offered vaccine in UK

August 4, 2021 Research and Development

UK experts are near announcing that all 16 and 17-year-olds should be offered a COVID vaccine in the UK, as …
News

Novartis set to launch new Zolgensma trial to expand use

August 3, 2021 Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing

Novartis has announced that it will launch a new Phase III study to expand the use of Zolgensma – the …
News

Cannabis-based oral spray could kill brain tumours, study to launch next year

August 3, 2021 Manufacturing and Production, Medical Communications, Research and Development

The NHS alongside cancer charities are set to launch a clinical trial to investigate the effects of a cannabis-based oral …
News
andrei_r_-_shutterstock_1935537274_720

Complix and Jiangsu Nhwa to collaborate on treatment of CNS Diseases

July 28, 2021 Research and Development

Complix has signed a global collaboration and license agreement with Jiangsu Nhwa Pharmaceutical Co, to develop Cell Penetrating Alphabodies (CPABs), …
News

US to ship nearly 10 million vaccine doses to Nigeria and South Africa

July 28, 2021 Research and Development

On Wednesday the US government will ship 4 million vaccine does to Nigeria and 5.66 million doses to South Africa. …
News

CanSino’s inhaled COVID vaccine performs well in early trials

July 28, 2021 Manufacturing and Production, Research and Development

Early-stage data, published in The Lancet on Monday, has shown CanSino Biologic’s inhaled COVID-19 vaccine was able to stimulate neutralising …
News

Biogen withdrew Aduhelm paper when asked for edits from JAMA

July 28, 2021 Research and Development

The makers of the controversial drug Aduhelm, Biogen, withdrew its paper that analysed the drug’s results that was submitted to …
News
astrazeneca_sign_sky

AstraZeneca & Regeneron to develop small molecule obesity treatment

July 28, 2021 Manufacturing and Production, Research and Development

AstraZeneca and Regeneron have announced a collaboration to research, develop and commercialise small molecule compounds directed against the GPR75 target …
News

BioNTech set to develop first mRNA malaria vaccine

July 27, 2021 Manufacturing and Production, Research and Development

Buliding on the success of its COVID-19 vaccine, BioNTech has announced the development of the first mRNA vaccine against malaria, …
News
The Gateway to Local Adoption Series

Latest content

Faron Pharmaceuticals appoints Heikki Jouttijärvi as Chief Technical Officer

April 2, 2026

Cambridge’s Grassroots Life Sciences Showcase Branches Out to Oxford & London

April 1, 2026

Doccla appoints Michael Macdonnell as Chief Strategy & Growth Officer and Deputy CEO

April 1, 2026

Bramacare launches new AI platform to improve eating disorder care

March 31, 2026

Doccla appoints Jonathan Serjeant as Chief Medical Officer

March 31, 2026